Chronic invasive fungal rhinosinusitis:: Two new cases and review of the literature
被引:9
作者:
Dufour, X
论文数: 0引用数: 0
h-index: 0
机构:CH Univ Poitiers, Dept Ear Nose & Throat, Poitiers, France
Dufour, X
Kauffmann-Lacroix, C
论文数: 0引用数: 0
h-index: 0
机构:CH Univ Poitiers, Dept Ear Nose & Throat, Poitiers, France
Kauffmann-Lacroix, C
Roblot, F
论文数: 0引用数: 0
h-index: 0
机构:CH Univ Poitiers, Dept Ear Nose & Throat, Poitiers, France
Roblot, F
Goujon, JM
论文数: 0引用数: 0
h-index: 0
机构:CH Univ Poitiers, Dept Ear Nose & Throat, Poitiers, France
Goujon, JM
Breux, JP
论文数: 0引用数: 0
h-index: 0
机构:CH Univ Poitiers, Dept Ear Nose & Throat, Poitiers, France
Breux, JP
Ferrié, JC
论文数: 0引用数: 0
h-index: 0
机构:CH Univ Poitiers, Dept Ear Nose & Throat, Poitiers, France
Ferrié, JC
Klossek, JM
论文数: 0引用数: 0
h-index: 0
机构:CH Univ Poitiers, Dept Ear Nose & Throat, Poitiers, France
Klossek, JM
机构:
[1] CH Univ Poitiers, Dept Ear Nose & Throat, Poitiers, France
[2] CH Univ Poitiers, Dept Maxillofacial Surg, Poitiers, France
[3] CH Univ Poitiers, Dept Mycol, Poitiers, France
[4] CH Univ Poitiers, Dept Infect Dis, Poitiers, France
[5] CH Univ Poitiers, Dept Histopathol, Poitiers, France
[6] CH Univ Poitiers, Dept Radiol, Poitiers, France
来源:
AMERICAN JOURNAL OF RHINOLOGY
|
2004年
/
18卷
/
04期
关键词:
D O I:
10.1177/194589240401800406
中图分类号:
R76 [耳鼻咽喉科学];
学科分类号:
100213 ;
摘要:
Background: Chronic invasive fungal rhinosinusitis is rare in the immunocompetent patient. Few cases have been published except for in a specific geographic area (Sudan, India). Methods and Results: We reported two new cases of chronic invasive fungal rhinosinusitis due to Aspergillus, which was successfully treated, to analyze the different clinical, radiological, and mycological criteria. Conclusion: Through these two new clinical cases and the analysis of the literature, we suggested, in the absence of general agreement on the surgical and medical management, the current strategies available for this rare pathology. New antifungal drugs seem to be an efficient alternative to classic antifungal agents, especially those that require an extended course of oral therapy for the chronic invasive form.